| Dr Brett Allen Fye, DC | |
|
1405 E Walton Ave, Altoona, PA 16602-7111 | |
| (814) 946-0279 | |
| (814) 946-9039 |
| Full Name | Dr Brett Allen Fye |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 20 Years |
| Location | 1405 E Walton Ave, Altoona, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699756205 | NPI | - | NPPES |
| 1009207200001 | Medicaid | PA | |
| 400544 | Other | PA | UPMC |
| FY1592850 | Other | PA | BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | DC009194 (Pennsylvania) | Primary |
| Provider Name | Altoona Chiropractic Life Center Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1316017247 PECOS PAC ID: 9830266790 Enrollment ID: O20080919000062 |
News Archive
Fibrosis in the kidney is one of the key causes of progressive renal failure. High levels of the inflammatory molecule TGF-β1 in the kidney tubules due to tissue damage can cause fibrosis as well as nephron degeneration, resulting in loss of kidney function. To clarify the mechanisms regulating TGF-β1-mediated renal fibrosis, Koesters et al expressed high levels of TGF-β1 in renal tubules of mice. Nephron degeneration in this system was mediated by decomposition of the tubular cells. These data suggest that TGF-β1 may play a novel role in cell death of renal cells, thus contributing to renal fibrosis.
Physicians should be comfortable referring some patients with chronic kidney disease (CKD) for effective stroke prevention surgery, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The findings indicate that CKD patients gain a significant benefit from the procedures without an increased risk of dying from surgical complications.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat prevalent inflammatory diseases, such as osteoarthritis (Ampion) and diabetic macular edema (Optina) and sexual dysfunction (Zertane) announced FDA acceptance of its POPE questionnaire, a modification of the Premature Ejaculation Profile (PEP) questionnaire that was used in the two successful Zertane Phase 3 clinical trials completed in Europe.
Cardiovascular disease is the leading cause of death in humans. Worldwide, as the population ages, the burden of treating heart failure is increasing; opportunities for heart transplantation cannot keep pace.
Meanwhile, news outlets report the latest on health exchanges in New Mexico, Oregon, Minnesota and Illinois.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brett Allen Fye, DC 1405 E Walton Ave, Altoona, PA 16602-7111 Ph: (814) 946-0279 | Dr Brett Allen Fye, DC 1405 E Walton Ave, Altoona, PA 16602-7111 Ph: (814) 946-0279 |
News Archive
Fibrosis in the kidney is one of the key causes of progressive renal failure. High levels of the inflammatory molecule TGF-β1 in the kidney tubules due to tissue damage can cause fibrosis as well as nephron degeneration, resulting in loss of kidney function. To clarify the mechanisms regulating TGF-β1-mediated renal fibrosis, Koesters et al expressed high levels of TGF-β1 in renal tubules of mice. Nephron degeneration in this system was mediated by decomposition of the tubular cells. These data suggest that TGF-β1 may play a novel role in cell death of renal cells, thus contributing to renal fibrosis.
Physicians should be comfortable referring some patients with chronic kidney disease (CKD) for effective stroke prevention surgery, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The findings indicate that CKD patients gain a significant benefit from the procedures without an increased risk of dying from surgical complications.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat prevalent inflammatory diseases, such as osteoarthritis (Ampion) and diabetic macular edema (Optina) and sexual dysfunction (Zertane) announced FDA acceptance of its POPE questionnaire, a modification of the Premature Ejaculation Profile (PEP) questionnaire that was used in the two successful Zertane Phase 3 clinical trials completed in Europe.
Cardiovascular disease is the leading cause of death in humans. Worldwide, as the population ages, the burden of treating heart failure is increasing; opportunities for heart transplantation cannot keep pace.
Meanwhile, news outlets report the latest on health exchanges in New Mexico, Oregon, Minnesota and Illinois.
› Verified 9 days ago
A Better Balance Chiropractic Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 210 E Plank Rd, Altoona, PA 16602 Phone: 814-296-2222 | |
Dr. Timothy Jason Clayton, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 332 W Plank Rd, Altoona, PA 16602 Phone: 814-941-5353 Fax: 814-283-0066 | |
Bonny F. Rowell, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1915 Valley View Blvd, Altoona, PA 16602 Phone: 814-941-1400 Fax: 814-941-0862 | |
Dr. Richard W Macdonald, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 332 W Plank Rd, Altoona, PA 16602 Phone: 814-941-5353 Fax: 814-941-5039 | |
Advanced Chiropractic Of Altoona Chiropractor Medicare: Medicare Enrolled Practice Location: 332 W Plank Road, Altoona, PA 16602 Phone: 814-941-5353 Fax: 814-283-0066 | |
Dr. Annette M Cronauer, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 332 W Plank Road, Altoona, PA 16602 Phone: 814-941-5353 Fax: 814-941-5039 | |
William Schroeder Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 217 Union Ave Fl 2, Altoona, PA 16602 Phone: 814-937-0925 Fax: 732-244-2775 |